Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist.
Cenci
E
E
Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Italy.
Mencacci
A
A
Del Sero
G
G
Fé d'Ostiani
C
C
Montagnoli
C
C
Bacci
A
A
Bistoni
F
F
Romani
L
L
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002176:Candida albicans / Q000187:drug effects*; D002177:Candidiasis / Q000188:drug therapy* / Q000276:immunology; D015169:Colony Count, Microbial; D004359:Drug Therapy, Combination; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D007111:Immunity, Cellular / Q000187:drug effects; D007371:Interferon-gamma / Q000032:analysis / Q000276:immunology; D015847:Interleukin-4 / Q000037:antagonists & inhibitors*; D051379:Mice; D008807:Mice, Inbred BALB C; D019948:Receptors, Interleukin-4 / Q000276:immunology / Q000627:therapeutic use*; D013047:Specific Pathogen-Free Organisms; D018417:Th1 Cells / Q000187:drug effects*
D000276:Adjuvants, Immunologic; D000935:Antifungal Agents; D019948:Receptors, Interleukin-4; D015847:Interleukin-4; D000666:Amphotericin B; D007371:Interferon-gamma; D015725:Fluconazole